These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2329853)

  • 1. [Chronic kidney insufficiency and respiratory muscle function. Changes induced by treatment with 1,25(OH)2D3].
    Gómez-Fernández P; Sánchez Agudo L; Calatrava JM
    Med Clin (Barc); 1990 Feb; 94(6):204-7. PubMed ID: 2329853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Respiratory system elastance and resistance measured by proportional assist ventilation in patients with respiratory muscle weakness].
    Oya Y; Ogawa M; Kawai M
    Rinsho Shinkeigaku; 2004; 44(4-5):268-73. PubMed ID: 15287508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of secondary hyperparathyroidism of predialysis chronic renal failure with low doses of 1,25(OH)2D3: humoral and histomorphometric results.
    Coen G; Mazzaferro S; Bonucci E; Ballanti P; Massimetti C; Donato G; Landi A; Smacchi A; Della Rocca C; Cinotti GA
    Miner Electrolyte Metab; 1986; 12(5-6):375-82. PubMed ID: 3492662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis treatment may improve inspiratory muscle strength and endurance.
    Weiner P; Zidan F; Zonder HB
    Isr J Med Sci; 1997 Feb; 33(2):134-8. PubMed ID: 9254876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function during calcitriol therapy in chronic renal failure.
    Bertoli M; Luisetto G; Ruffatti A; Urso M; Romagnoli G
    Clin Nephrol; 1990 Feb; 33(2):98-102. PubMed ID: 2311310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 metabolites in chronic renal failure and after renal transplantation.
    Lucas PA; Woodhead JS; Brown RC
    Nephrol Dial Transplant; 1988; 3(1):70-6. PubMed ID: 3132643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
    Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Specific inspiratory muscle training in chronic hemodialysis].
    Weiner P; Ganem R; Zamir D; Zonder H
    Harefuah; 1996 Jan; 130(2):73-6, 144. PubMed ID: 8846980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of parathyroid hormone and 1,25 (OH)2D3 on nerve conductance in patients on maintenance hemodialysis.
    Ivić MA; Kostić S; Strahinjić S; Stefanović V
    Acta Med Iugosl; 1989; 43(5):349-55. PubMed ID: 2626971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calciuric response to 1,25-(OH)2D3 in early renal failure.
    Cremer B; Lübbers E; Klooker P; Schmidt-Gayk H; Ritz E
    Miner Electrolyte Metab; 1985; 11(3):182-5. PubMed ID: 3839286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D metabolites in renal insufficiency and other vitamin D disorders of children.
    Chesney RW; Hamstra AJ; Phelps M; DeLuca HF
    Kidney Int Suppl; 1983 Nov; 15():S63-9. PubMed ID: 6584678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Parathormone and vitamin d3-metabolites in healthy children and children with chronic renal failure before and after kidney transplantation].
    Pistor K; Reinhardt D; Grosse-Hohmann E; Keck E
    Monatsschr Kinderheilkd; 1982 Sep; 130(9):714-20. PubMed ID: 6755227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe proximal myopathy in advanced renal failure. Diagnosis and management.
    Adeniyi O; Agaba EI; King M; Servilla KS; Massie L; Tzamaloukas AH
    Afr J Med Med Sci; 2004 Dec; 33(4):385-8. PubMed ID: 15977450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vitamin disturbances in chronic renal insufficiency. II. Fat soluble vitamins].
    Pietrzak I
    Przegl Lek; 1996; 53(1):29-32. PubMed ID: 8711172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.